Expert Q&A: Labs Must Take a Greater Role in Guiding Clinicians About Abnormal Data
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Yet, despite these declines, Q1 was neither as bad as expected nor totally devoid of positive signs for the future.
What should pathology groups and labs do in order to attract and maintain clinical talent in today’s economy?
After a significant lull, M&As in the lab diagnostics space heated up in May, with several key deals announced.
So far, it appears many post-PHE COVID-19 tests will be panels for detecting and differentiating among multiple respiratory viruses.
A recent report offers new insight into bankruptcy trends within the sector starting before the COVID-19 pandemic.
A written policy helps establish your right to do excluded persons checks and take appropriate actions if they come back positive.
In recent key cases, the national drug retailer must stand trial for failing to protect customers from faulty Theranos products.
The new codes have garnered attention as a future mechanism for additional reimbursement and thus deserve further discussion.
Hiring, retaining, or simply doing business with the wrong people may expose your lab to significant financial penalties.
A recent False Claims Act settlement from Kentucky represents an unusual variation on a common theme.